Thematische Bibliographien / Oncogeriatrics

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen
Bücher
Buchteile
Konferenzberichte

Auswahl der wissenschaftlichen Literatur zum Thema „Oncogeriatrics“

Autor: Grafiati

Veröffentlicht am 16. November 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Oncogeriatrics" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Oncogeriatrics"

Monfardini, Silvio, Francesco Perrone und Lodovico Balducci. „Pitfalls in Oncogeriatrics“. Cancers 15, Nr. 11 (25.05.2023): 2910. http://dx.doi.org/10.3390/cancers15112910.

Der volle Inhalt der Quelle

Annotation:

An oncogeriatric interdisciplinary activity exists only in a minority of high-income countries, and it is almost absent in those with lower incomes. Considering topics, sessions, and tracks in the main meetings and conferences of the major Oncological Societies in Europe and worldwide, the USA excluded, little attention has thus far been paid to the problem of cancer in the elderly. Again, with the exception of the USA, the major cooperative groups, for example, the EORTC in Europe, have only dedicated marginal attention to the research of cancer in the elderly. Despite major shortcomings, professionals interested in geriatric oncology have taken a number of important initiatives to highlight the benefits of this particular activity, including the organization of an international society (Société Internationale de Oncogeriatrie, or SIOG). In spite of these efforts, the authors believe that the management of cancer in the older population is still encountering several important and generalized pitfalls. The main obstacle is the grossly inadequate number of geriatricians and clinical oncologists necessary to an integrated care of the ever-expanding aging population, but other hurdles have been reported. Additionally, the prejudice of ageism can lead to missing potential resources for the development of a generalized oncogeriatric approach.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Rey, Jean-Baptiste, Damien Parent und Stephane Perin. „Oncogeriatrics joint consultations: When pharmacists improve patients' management together with oncogeriatrics physician.“ Journal of Clinical Oncology 32, Nr. 31_suppl (01.11.2014): 79. http://dx.doi.org/10.1200/jco.2014.32.31_suppl.79.

Der volle Inhalt der Quelle

Annotation:

79 Background: Elderly patients often have several diseases and therefore polymedicated. Comorbidities and treatments may interfere with management of oncological patients. Methods: The objectives of this project are 1) to ensure a proper understanding of patients regarding their treatment, 2) to perform a pharmaceutical analysis of patients’ prescription, 3) to propose changes to the patients’ doctors (general practitioners and physicians of the Institute) to prevent and reduce adverse drug events. The project combines medical and pharmaceutical expertise around the patient to optimize their care coordinated with the action of a "disease professional” and a "drug professional " with a particularly vulnerable population. Results: Since the project began, more than 100 patients benefited from these joint consultations, thus establishing a network between the Institute and the general practionners supporting our patients. Optimization of drug treatment and reduction of iatrogenic events avoids the complications and hospitalizations extensions and / or re-hospitalization. The pharmaceutical intervention documented in the medical records of patients (explaining terms of the intervention) and the transmission of the report to "pharmaceutical consultation" to physician 1) improves the management of patients (reduction potential iatrogenic events – e.g. risk of falling by orthostatic hypotension) and 2) allows the referring physician to optimize patient care. Conclusions: Launched in 2010, the project entered its fourth year of existence and continues.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cohen, Q., P. Bocquet, A. Sebaux, J. L. Novella und A. A. Zulfiqar. „P-165: Oncogeriatrics: multidisciplinary management“. European Geriatric Medicine 6 (September 2015): S76. http://dx.doi.org/10.1016/s1878-7649(15)30265-5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Carvalho, Dayara de Nazaré Rosa de, Viviane Ferraz Ferreira de Aguiar, Lorena Nayara Alves Neves, Celice Ruanda Oliveira Sobrinho, Dandara de Fátima Ribeiro Bendelaque, Rafael Everton Assunção Ribeiro da Costa, Djenanne Simonsen Augusto de Carvalho Caetano et al. „Clinical-epidemiological profile of the oncogeriatric patient served in high complexity public hospitals in the State of Pará in the historical series 2014-2018“. Research, Society and Development 9, Nr. 9 (15.08.2020): e189996821. http://dx.doi.org/10.33448/rsd-v9i9.6821.

Der volle Inhalt der Quelle

Annotation:

Introduction: Cancer is classified as a set of cells that have a disordered growth and without specific functions, in which they affect the systems, being that the main population affected is the elderly, due to the associated risk factors, being highlighted the process of cell aging. Objective: to trace the clinical-epidemiological profile of the oncogeriatric patient seen in public hospitals of high complexity in the State of Pará, in the 2014-2018 historical series. Methodology: This is an epidemiological, descriptive retrospective study with a quantitative approach. The study was carried out in the month of June 2020 with information from secondary data, coming from the Hospital Cancer Registry Computerization System for oncogeriatric patients seen in high complexity hospitals in the state of Pará in the period from 2014 to 2018. Results: if the total of 8,184 oncogeriatrics patients seen in hospitals in Pará and the distribution of sociodemographic data found the predominance of the male population, in the age group between 60 and 69 years old, brown race, most have only incomplete fundamental level. Conclusion: It is necessary for professionals to carry out health education practices for this public, in order to raise awareness and encourage self-care, so that these rates are overcome and they can age with a better quality of life.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kenig, Jakub. „Oncogeriatrics (part 8.). Frailty screening tools“. Nowotwory. Journal of Oncology 70, Nr. 5 (05.10.2020): 184–86. http://dx.doi.org/10.5603/njo.a2020.0039.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kenig, Jakub. „Oncogeriatrics (part 2.). Normal and pathological ageing“. Nowotwory. Journal of Oncology 69, Nr. 3-4 (31.10.2019): 146–49. http://dx.doi.org/10.5603/njo.2019.0027.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Falandry, Claire, Eric Gilson und K. Lenhard Rudolph. „Are aging biomarkers clinically relevant in oncogeriatrics?“ Critical Reviews in Oncology/Hematology 85, Nr. 3 (März 2013): 257–65. http://dx.doi.org/10.1016/j.critrevonc.2012.08.004.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cudennec, T., S. Moulias, S. Labrune, T. Chinet und L. Teillet. „P.9 Oncogeriatrics in pneumology a growing activity“. Critical Reviews in Oncology/Hematology 64 (November 2007): S38. http://dx.doi.org/10.1016/s1040-8428(13)70182-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

López Pardo, P., M. M. Cavanagh Podesta, A. M. Sánchez Peña, M. Soria Tristán, L. Díaz Paniagua, S. Enrech Francés, M. T. Díaz Puente, J. M. Martín Martínez und P. López-Dóriga Bonnardeaux. „Prevalence of Cognitive Impairment in our Oncogeriatrics Program“. Journal of Geriatric Oncology 13, Nr. 8 (Oktober 2022): S69. http://dx.doi.org/10.1016/s1879-4068(22)00408-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Katsila, Theodora, George P. Patrinos und Dimitrios Kardamakis. „Searching for Clinically Relevant Biomarkers in Geriatric Oncology“. BioMed Research International 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/3793154.

Der volle Inhalt der Quelle

Annotation:

Ageing, which is associated with a progressive decline and functional deterioration in multiple organ systems, is highly heterogeneous, both inter- and intraindividually. For this, tailored-made theranostics and optimum patient stratification become fundamental, when decision-making in elderly patients is considered. In particular, when cancer incidence and cancer-related mortality and morbidity are taken into account, elderly patient care is a public health concern. In this review, we focus on oncogeriatrics and highlight current opportunities and challenges with an emphasis on the unmet need of clinically relevant biomarkers in elderly cancer patients. We performed a literature search on PubMed and Scopus databases for articles published in English between 2000 and 2017 coupled to text mining and analysis. Considering the top insights, we derived from our literature analysis that information knowledge needs to turn into knowledge growth in oncogeriatrics towards clinically relevant biomarkers, cost-effective practices, updated educational schemes for health professionals (in particular, geriatricians and oncologists), and awareness of ethical issues. We conclude with an interdisciplinary call to omics, geriatricians, oncologists, informatics, and policy-makers communities that Big Data should be translated into decision-making in the clinic.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Oncogeriatrics"

Desbruyères, Clément. „L’épreuve du cancer à un âge avancé : pratiques médicales et négociations du soin en oncogériatrie“. Electronic Thesis or Diss., Brest, 2024. http://www.theses.fr/2024BRES0036.

Der volle Inhalt der Quelle

Annotation:

Cette thèse étudie l’épreuve du cancer à un âge avancé, en situant cette dernière à l’interface de pratiques professionnelles et de logiques individuelles et familiales. Certains malades âgés vivent déjà avec diverses fragilités susceptibles de limiter les bénéfices attendus du traitement envisagé par les médecins. Face au risque de voir leur âge chronologique déterminer à lui seul l’accès aux thérapeutiques, le dispositif oncogériatrique est envisagé comme permettant d'orienter les processus décisionnels médicaux vers davantage de justice, en adaptant les traitements anticancéreux à la qualification de la fragilité des personnes. La mise en oeuvre d’un tel dispositif interroge les modes d’appropriation du vieillissement par les cancérologues, comme la manière dont l’épreuve du cancer est pensée, exprimée et agie par les vieilles personnes incluses dans ce dispositif de soin. Pour ce faire, j’ai mené une enquête qualitative combinant des observations in situ dans deux établissements de santé bretons et des entretiens semi-directifs auprès de professionnels de santé, de malades et de certains de leurs proches. L’analyse a permis d’appréhender l’épreuve du cancer à un âge avancé comme façonnée par des différents temps et temporalités, tant du côté des malades que des professionnels soignants. Elle a également conduit à apporter un nouvel éclairage sur les négociations du soin en cancérologie, en partie déterminées par l’âge et la qualification de fragilité des malades du cancer
This research aims at understanding the trial of cancer when it is diagnosed at an advanced age, considering it at the interface of professional practices and individual and family reasoning. Some older patients already live with various frailties, which can reduce the expected benefits of the treatment envisaged by physicians. Facing the risk of seeing their chronological age determining the access to therapies, oncogeriatrics is believed to guide medical decision-making processes towards greater fairness, through the assessment of patient’s frailty. The implementation of this approach questions the ways in which oncologist engage with aging, as well as how the trial of cancer is conceptualized, expressed, and addressed by elderly individuals included in such a care system. To do so, I conducted a qualitative investigation combining in situ observations in two healthcare establishments in Brittany (France) and semi-structured interviews with healthcare professionals, patients, and some of their relatives. The analysis allowed to highlight the trial of cancer at an advanced age as shaped by different times and temporalities, both from the perspective of patients and professionals. It has also led to shed new light on care negotiations in the field of oncology, partly determined by the age and qualified frailty of cancer patients

APA, Harvard, Vancouver, ISO und andere Zitierweisen

GIANNOTTI, CHIARA. „GERIATRIC CO-MANAGED CARE OF OLDER ADULTS ADMITTED TO A SURGICAL SERVICE FOR GASTROINTESTINAL CANCER. A PROPENSITY SCORE ANALYSIS“. Doctoral thesis, Università degli studi di Genova, 2021. http://hdl.handle.net/11567/1047014.

Der volle Inhalt der Quelle

Annotation:

Surgery represents the key treatment for the majority of g.i. cancers and the advances in anaesthesia, perioperative medicine, pain medicine and postoperative critical care, as well as surgical techniques, have changed the risk-to-benefit balance of surgery in many high-risk patients. Many more medically complex patients have become eligible for surgical interventions, including those who are older, frail, or have multiple comorbidities, a decline in physiological reserve, impaired nutrition or cognition and are at higher risk for poor outcomes. Geriatric patients require multimodality and multispecialty interventions to improve their care geriatric but geriatric comanagement (GC) in general surgery is rarely implemented. A single-centre observational study was performed within an Italian teaching hospital with a tertiary referral practice for oncological surgery between January 2015 and December 2019. Eligibility criteria were patients aged at least 70 years, with colorectal, gastric, and hepatopancreaticobiliary cancer, admitted to the Oncological Surgery of Policlinico San Martino of Genoa, who underwent elective surgical procedures or palliative treatments and required a hospital stay of at least 1 day. This before and after study aimed to examine the effectiveness of the GC by comparing patient outcomes before and after the implementation of a dedicated geriatric service in November 2018. During the first three years older cancer patients underwent a CGA in order to stratify patients’ frailty and performance status prior to surgery. Starting from November 1st 2018, a GC was implemented in the surgical ward following the appointment of a fulltime consultant geriatrician. This upgraded model of geriatric care consisted of the initiation of daily targeted geriatrician-led ward rounds focusing on older cancer patients. A total of 235 patients were admitted to the oncological surgery ward during the entire study period: 122 (52%) before November 1st 2018 (control group) and 113 (48%) between November 1st 2018 and November 1st 2019 (GC group). Comparison of the two cohorts demonstrated that patients in the control group were older (median age [IQR] 81.50 [78.00, 85.00] years vs 79.00 [76.00, 83.00] years; p < 0.004) and predominantly male (79 [64.8%] vs 59 [52.2%]; p < 0.05). Average Frailty Index scores were 0.12 in the control group and 0.18 in the intervention group (p <0.01), corresponding to a pre-frail phenotype in both cases. Patients from the GC group demonstrated a significant decrease in grade I-V postoperative complications (OR = 0.53 (95%CI 0.32, 0.87), p <. 0.012), which was also confirmed by our adjusted analysis according to the propensity score (weighted OR = OR = 0.37 (95%CI 0.27, 0.50), p < 0.001). Indeed, the GC group exhibited significantly lower CCI scores (β coefficient [SE], GC vs control group -10.2 (95%CI -17.3, -3.8), p < 0.009) as compared to the patient from the control group. Specifically, in those patients who received GC, mean CCI score was lower by 12 points, which represents a statistically significant decrease after adjustment (β coefficient [SE], intervention vs controls -15.6 (95%CI -23.8, -7.33), p < 0.001). No significant differences between the two groups were observed when considering 90-day and 1-year mortality. Of note, the majority of deaths in the GC group were cancer related (i.e., due to progression of disease). A higher number of patients were deemed eligible to start anticancer treatment in the GC group as compared to the patient from the control group [21 (48%) vs. 35 (69%), p = 0.063]. In conclusion, GC can improve the perioperative management of older cancer patients undergoing elective g.i. surgery by potentially reducing postoperative complications. To our knowledge, amongst the few studies analysing the effectiveness of GC in patient who are candidate to major oncological surgery, this is one of the few ones showing positive results in terms of reduction of postoperative complications.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Joannette, Sonia. „Signification accordée à l'approche oncogériatrique intégrée par des personnes âgées atteintes de cancer“. Mémoire, Université de Sherbrooke, 2016. http://hdl.handle.net/11143/8190.

Der volle Inhalt der Quelle

Annotation:

Résumé: Introduction : En raison du parcours de la maladie et de son traitement multimodal, les personnes âgées atteintes de cancer sont particulièrement exposées aux problèmes de fragmentation des soins. Les experts au niveau international s’entendent pour dire qu’il est nécessaire de mettre en œuvre une approche oncogériatrique intégrée (AOGI). Cette approche vise à offrir aux personnes âgées atteintes de cancer des soins de qualité. Or, la signification accordée à l’AOGI varie en fonction des disciplines, des acteurs et des contextes. Par ailleurs, la perspective des personnes âgées atteintes de cancer, premières concernées, par cette approche, n’est pas abordée dans les études. Objectif : L’objectif de cette étude est de comprendre la signification de l’approche oncogériatrique intégrée selon la perspective de la personne âgée atteinte de cancer. Méthode : L’étude phénoménologique herméneutique est basée sur la méthode de van Manen (1990) et s’appuie sur le cadre théorique de la théorie de l’Humain en devenir (Parse, 1992). Elle s’est effectuée auprès de 10 personnes âgées de plus de 70 ans, atteintes de divers cancers, avec différents parcours de soins et traitées dans un centre intégré de cancérologie. Les données ont été recueillies lors d’entrevues semi-structurées enregistrées en audio numériques. Les verbatim ont été transcrits. Les analyses qualitatives ont été interprétatives (unités de sens, catégories, thèmes). Résultats : Les résultats présentent la description riche des cinq thèmes essentiels de la signification accordée à l’AOGI: être avec la personne transformée, dans la singularité de l’expérience vécue, pour l’aider à composer avec les paradoxes liés au vieillissement, au cancer et à son traitement afin qu’elle puisse continuer d’être ce qu’elle est. Conclusion : Cette étude pose les balises, fondées sur la perspective des personnes âgées atteintes de cancer pour l’amélioration de la qualité et de l'intégration des soins dans un contexte où l’AOGI est émergente.
Abstract: Introduction: Due to the course of the disease and its multimodal treatment, elderly persons affected with cancer are particularly vulnerable to problems of fragmentation of care. Internationally, experts agree that it is essential to implement an integrated oncogeriatric approach (IOGA). This approach aims to provide quality of care to the elderly to meet the globality of their needs. However, the meaning attributed to IOGA varies between disciplines, stakeholders and contexts. Furthermore, there is limited information in the literature about the perspective of the elderly person affected with cancer, even though they are at the center of this approach. Objective: The objective of this study is to understand the meaning of an integrated oncogeriatric approach from the perspective of the elderly person affected with cancer. Method: The hermeneutic phenomenological study is based on van Manen (1990) and follows the theoretical frame of The human becoming theory (Parse, 1992). It was conducted among 10 elderly persons of 70 years and older, with different types of cancers, with different care pathways, treated at an integrated cancer center. Data was collected using semi-structured interviews and recorded in digital audio. Verbatim were transcribed. The qualitative analyses were interpretative (meaning units, categories, themes). Results: The results provide rich descriptions of the five key themes of the meaning attributed to AOGI: Being with the transformed individual in the singularity of the lived experience in order to help him/her deal with the paradoxes linked to aging, to cancer and its treatment in order for them to continue to be what he/she is. Conclusion: This study, based on the perspective of the elderly person treated for cancer, lays down the guidelines for the improvement of the quality and integration of cares he development of better care in a context where IOGA is emerging.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Luz, Laércio Lima. „Avaliação multidimensional da saúde de idosos com câncer de próstata e o The Vulnerable Elders Survey 13 (VES-13) como instrumento de triagem em oncogeriatria“. reponame:Repositório Institucional da FIOCRUZ, 2015. https://www.arca.fiocruz.br/handle/icict/12829.

Der volle Inhalt der Quelle

Annotation:

Made available in DSpace on 2016-02-26T13:26:06Z (GMT). No. of bitstreams: 2 175.pdf: 1647711 bytes, checksum: 706a8af5e3f3671529f815fe707ea4dc (MD5) license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2015
Introdução: A realização de uma avaliação multidimensional em idosos é recomendada antes da definição do tratamento oncológico. Em anos recentes, tem sido proposta a utilização de instrumentos de triagem, tais como o The Vulnerable Elderly Survey 13 (VES-13), que possibilitam identificar os indivíduos hígidos, reservando a avaliação multidimensional apenas para aqueles com maior probabilidade de alterações da saúde global.Objetivos: Realizar a adaptação transcultural do VES-13 para utilização na população idosa brasileira com câncer e avaliar as propriedades psicométricas da versão brasileira do VES-13; Caracterizar a condição de saúde global de idosos com câncer de próstata por meio de uma Avaliação Geriátrica Multidimensional (AGM) e avaliar a acurácia do VES-13 como instrumento de triagem em oncogeriatria; Analisar as dimensões da saúde global associadas à vulnerabilidade e avaliar o poder discriminatório do VES-13 para novas composições de AGM constituídas com as dimensões associadas à vulnerabilidade na população de estudo. (...)
Conclusões: Considerou-se que a versão brasileira do VES-13 se mostrou adequada e foi bem compreendida pelos idosos e suas propriedades psicométricas foram consideradas consistentes. Tendo em vista que a sensibilidade e o valor preditivo negativo são os elementos mais relevantes para um bom instrumento de triagem em oncogeriatria, o ponto de corte alternativo do VES-13 parece ser o mais indicado para a identificação de indivíduos vulneráveis em populações mais jovens e hígidas, como a deste estudo. Para populações com características similares às observadas neste estudo, uma composição de AGM que contemple funcionalidade em AVDs, funcionalidade em AIVDs, estado emocional, comorbidade, estado nutricional e uso de medicamentos parece ser a mais indicada como padrão-ouro para a avaliação da acurácia do VES-13.
Introduction: A multidimensional assessment is recommended for older adults before the definition of cancer treatment. In recent years, the use of screening tools, such as The Vulnerable Elderly Survey 13 (VES-13), which allow to identify healthy individuals, is being proposed in order to preserve the multidimensional evaluation only for those most likely to have deficiencies in their global health .Objectives: To perform the cross-cultural adaptation of the VES-13 for use in the elderly population with cancer and evaluate the psychometric properties of the Brazilian version of the VES-13; To characterize the overall health status of elderly patients with prostate cancer through a Multidimensional Geriatric Assessment (AGM) and evaluate the accuracy of VES-13 as a screening tool in geriatric oncology; To analyze the global health dimensions associated with vulnerability and to evaluate the discriminatory power of VES-13 for new AGM models, composed with the dimensions associated with vulnerability in this population. (...) Conclusions: The Brazilian version of VES-13 was adequate and was well understood by seniors and their psychometric properties were considered consistent. Given that sensitivity and negative predictive value are the most important elements for a good screening tool in geriatric oncology, the alternative cut-off point for the VES-13 seems to be the most appropriate for identifying vulnerable individuals in younger and healthy populations, like the one in this study. For populations with characteristics similar to those observed in this study, an AGM composition including ADLs functionality, IADLs functionality, emotional state, comorbidity, nutritional status and use of medications seems to be the most suitable as the gold standard for assessing the accuracy of VES-13. (AU)^ien

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Oncogeriatrics"

Ananda, Sarah, Andre Filipe Junqueira, Carolina Jacobina und Alexandra Mendes Barreto Arantes. Cuidados Paliativos e Oncogeriatria. DOC, 2021. http://dx.doi.org/10.56271/978.65.87679.19.8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ananda, Sarah, Andre Filipe Junqueira, Carolina Jacobina und Alexandra Mendes Barreto Arantes. Cuidados Paliativos e Oncogeriatria. 2. Aufl. DOC, 2022. http://dx.doi.org/10.56271/978.65.87679.73.0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Oncogeriatrics"

Zulian, G. B. „The Challenges of Oncogeriatrics“. In Management of Aging, 165–73. Basel: KARGER, 1999. http://dx.doi.org/10.1159/000061434.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Stéphane, Sanchez, Olivier Guerin und Patrick Mallea. „Monitoring and Clinical Research in Oncogeriatrics“. In Encyclopedia of Gerontology and Population Aging, 3286–87. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-22009-9_768.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Stéphane, Sanchez, Olivier Guerin und Patrick Mallea. „Monitoring and Clinical Research in Oncogeriatrics“. In Encyclopedia of Gerontology and Population Aging, 1–2. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-69892-2_768-1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

van Leeuwen, Barbara, und Maarten van der Laan. „Treatment Decisions Based on Treatment Goals of Oncogeriatric Patients“. In Personalized Specialty Care, 25–30. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63746-0_4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Vieira, Natália Barros Salgado, Aline Oliveira Aguiar Antônio, Vitor Farias Martins, Laura Dourado Paiva, Milagres Araújo Nascimento, Rebeca Moreno Grosso Fleury, Sarah Joanny da Silva Pereira und Thales Pádua Xavier. „AVANÇOS E DESAFIOS DO CUIDADO MULTIDISCIPLINAR EM ONCOGERIATRIA“. In Science e saúde: atuação multiprofissional na oncologia, Volume 1, 103–12. Editora e-Publicar, 2022. http://dx.doi.org/10.47402/ed.ep.c2022120411344.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Oneti, Ciro Félix, Raquel De Souza Praia, Inez Siqueira Santiago Neta, Andréa Rebouças Mortágua, Michelle Silva Costa, Euler Esteves Ribeiro, Ednéa Aguiar Maia Ribeiro, Juliana Maria Brandão Ozores, Priscila Lyra Mesquita und Arthenize Riame Praia G. C. Araújo. „O PERFIL DO ENFERMEIRO FRENTE A MULTIDISCIPLINARIDADE EM ONCOGERIATRIA“. In Ciências da Saúde: Da Teoria à Prática 2, 246–54. Atena Editora, 2019. http://dx.doi.org/10.22533/at.ed.94119130626.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Souza de Brito, Daniela, Maria Eduarda Marinho Caúla Alcântara und Flávia Mie Sakaguchi Barros. „Escuta humanizada a paciente da oncogeriatria: um relato de experiência“. In Internacional Saúde Única (Interface Mundial). 3. Aufl. Even3, 2021. http://dx.doi.org/10.29327/icidsuim2021.380289.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Oncogeriatrics"

Ruppert, L., CP Mortier, I. Lelievre und B. Phan. „4CPS-349 Role of hospital pharmacists in oncogeriatric consultations: a retrospective study“. In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.181.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Langaro, Elizane, Nathália de Souza Rodrigues und Charise Dallazem Bertol. „O papel do farmacêutico na oncogeriatria: monitoramento, gestão e cuidado“. In VII Congresso Internacional de Estudos do Envelhecimento Humano. Congresse.me, 2024. http://dx.doi.org/10.54265/ulsu4556.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!